Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Tongyang Xuanbi Recipe is a Traditional Chinese Medicine (TCM) herbal formula primarily developed for the treatment of cardiovascular conditions, specifically coronary heart disease (CHD) and angina pectoris associated with "phlegm-stasis obstruction" syndrome. The formula is designed to "unblock Yang" and "dispel phlegm," addressing the underlying TCM pathology of chest obstruction (Xiong Bi). Pharmacologically, the recipe has been shown to reduce inflammatory markers such as C-reactive protein (CRP), interleukin-6 (IL-6), and tumor necrosis factor-alpha (TNF-α), while also improving lipid profiles and myocardial blood supply. It is frequently studied as an adjunctive therapy to standard Western medical treatments, including antiplatelet agents and statins, to enhance clinical efficacy and reduce the recurrence of angina symptoms.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Tongyang Xuanbi Recipe.